Mel Sorensen - Nov 20, 2025 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role: President and CEO, Director
Signature: /s/ J. Mel Sorensen
Stock symbol: GRTX
Transactions as of: Nov 20, 2025
Transactions value $: -$1,407
Form type: 4
Date filed: 11/24/2025, 04:42 PM
Previous filing: May 5, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sorensen Mel	President and CEO, Director	C/O GALERA THERAPEUTICS, INC., 101 LINDENWOOD DRIVE, SUITE 225, MALVERN	/s/ J. Mel Sorensen	2025-11-24	0001444783

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GRTX	Common Stock	Sale	-$1.41K	-70K	-26.41%	$0.02	195K	Nov 20, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.02 to $0.0201, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.02 to $0.0201, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.